Skip to content

Q2 FY25 Earnings Results

Q2 FY25 earnings, Jul–Sep 2024: 5,887 Indian listed companies have reported; median profit growth is +6.2% on last year. Quarter ended 30 Sep 2024.

Clear filters 101–200 of 263
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
MONOPHARMA Mono Pharmacare LtdHealthcare87up+29.9%n/a20.0%1.30No estimate
NOVARTIND Novartis India LtdHealthcare87up+10.1%down−5.4%20down−16.7%8.27No estimate
OSELDEVICE OSEL Devices LtdHealthcare87up+70.6%n/a8up+60.0%4.97No estimate
VIMTALABS Vimta Labs LtdHealthcare85up+32.8%up+13.3%15up+150.0%3.44No estimate
Oriental Remedies & Herbals Ltd Healthcare84n/an/a5n/a—No estimate
GLENINDUSTRIESLTD Healthcare84n/an/a8n/a4.84No estimate
HESTERBIO Hester Biosciences LtdHealthcare84up+20.0%up+2.4%8up+100.0%9.64No estimate
INFINIUM Infinium Pharmachem LtdHealthcare83up+36.1%n/a5down−16.7%3.17No estimate
MANGALAM Mangalam Drugs and Organics LtdHealthcare80down−2.0%up+4.5%3n/a1.70No estimate
HALEOSLABS Haleos Labs LimitedHealthcare78up+13.3%down−15.2%3n/a15.45No estimate
BALAXI Balaxi Pharmaceuticals LtdHealthcare77up+41.4%up+17.9%5down−68.2%0.83No estimate
SATKARTAR Sat Kartar Life LtdHealthcare76n/an/a4n/a3.30No estimate
JAGSNPHARM Jagsonpal Pharmaceuticals LtdHealthcare75up+29.3%up+23.0%11up+57.1%1.73No estimate
BALPHARMA Bal Pharma LtdHealthcare74down−20.4%down−0.9%1up+7.2%0.65No estimate
BPLPHARMA Bharat Parenterals LtdHealthcare72up+19.8%down−22.6%−18down−820.6%−11.50No estimate
SAMRATPHARMACHEMLTD Healthcare70down−12.0%down−13.2%3n/a8.61No estimate
COREPARENT Core Healthcare LtdHealthcare68down−1.4%n/a60.0%3.34No estimate
ZENITHDRUG Zenith Drugs LtdHealthcare68down−1.4%n/a60.0%3.34No estimate
ZOTA Zota Health Care LtdHealthcare67up+48.9%up+19.6%−12n/a−4.41No estimate
AMANTA Amanta Healthcare LtdHealthcare67n/adown−2.0%2n/a0.78No estimate
CHANDRABHAGATPHARMALTD Healthcare65down−45.4%n/a10.0%0.90No estimate
DENTALKART Vasa Denticity LtdHealthcare59up+45.9%up+10.9%5up+44.0%3.35No estimate
FABTECH Fabtech Technologies LtdHealthcare59n/an/a5n/a1.58No estimate
MURAEORGANISORLTD Healthcare58up+13,390.7%up+25,121.7%1n/a0.00No estimate
LAXMIDENTL Laxmi Dental LtdHealthcare57n/adown−5.0%6n/a2.12No estimate
SOTAC Sotac Pharmaceuticals LtdHealthcare53up+1.9%n/a20.0%1.73No estimate
HEMANTSURGICALINDUSTRIESLTD Healthcare49up+2.1%n/a3down−25.0%3.05No estimate
PARNAXLAB Parnax Lab LtdHealthcare48up+13.5%down−3.5%3up+82.9%2.97No estimate
INFLUX Influx Healthtech LtdHealthcare48n/an/a6n/a3.10No estimate
DENISCHEMLABLTD Healthcare48up+5.3%up+15.9%4up+39.0%2.54No estimate
SYSCHEMINDIALTD Syschem (India) LtdHealthcare48up+28.1%down−45.7%−1down−157.1%−0.16No estimate
KILITCH Kilitch Drugs (India) LtdHealthcare47up+15.2%up+41.9%9up+69.2%2.46No estimate
ASTONEALABSLTD Healthcare47n/an/a2n/a2.76No estimate
MEDICAMEQ Medicamen Biotech LtdHealthcare45up+2.8%up+3.9%1down−38.1%1.15No estimate
EVERESTORGANICSLTD Healthcare44down−10.9%up+35.7%1up+2,366.7%0.92No estimate
SAKAR Sakar Healthcare LtdHealthcare43up+26.5%up+4.9%5up+25.0%2.21No estimate
MADHAVBAUG Vaidya Sane Ayurved Laboratories LtdHealthcare42down−17.6%n/a4up+300.0%3.58No estimate
JENBURPH Jenburkt Pharmaceuticals LtdHealthcare41up+7.7%up+26.7%10up+31.1%21.75No estimate
NATCAPSUQ Natural Capsules LtdHealthcare41up+9.9%up+5.2%−1down−139.1%−0.60No estimate
LYKALABS Lyka Labs LtdHealthcare41up+47.1%up+36.7%2n/a0.59No estimate
ADESHWARLTD Adeshwar Meditex LtdHealthcare41down−11.6%n/a1up+23.3%0.62No estimate
BAFNAPH Bafna Pharmaceuticals LtdHealthcare40down−0.9%up+21.1%3up+5.6%1.11No estimate
JFLLIFE JFL Life Sciences LtdHealthcare40n/aup+314.2%1n/a0.44No estimate
LASA Lasa Supergenerics LtdHealthcare39up+62.1%up+27.7%−3n/a−0.64No estimate
MEDICO Medico Remedies LtdHealthcare39down−7.1%up+27.8%2down−36.2%0.19No estimate
QMSMEDI QMS Medical Allied Services LtdHealthcare37n/an/a4n/a1.78No estimate
Vysali Pharmaceuticals Ltd Healthcare36n/an/a6n/a6.87No estimate
GUJTHEM Gujarat Themis Biosyn LtdHealthcare35down−12.5%down−10.3%11down−15.4%0.97No estimate
PAR Par Drugs & Chemicals LtdHealthcare35up+33.9%up+53.3%9up+75.9%6.99No estimate
GENNEXLABORATORIESLTD Healthcare33up+83.6%up+17.9%5up+75.2%0.21No estimate
ANGLIFESCIENCESINDIALTD Healthcare33down−1.1%up+78.6%−2n/a−1.60No estimate
WALPAR Walpar Nutritions LtdHealthcare33up+4.5%n/a1up+116.9%1.37No estimate
SGRL Shree Ganesh Remedies LtdHealthcare32down−3.3%up+30.5%6down−2.0%5.00No estimate
CORALLABORATORIESLTD Healthcare32up+39.2%up+1.8%6up+6.3%17.86No estimate
NURECA Nureca LtdHealthcare31down−0.5%up+53.9%0down−116.6%−0.48No estimate
LACTOSEINDIALTD Lactose (India) LtdHealthcare30up+24.6%up+3.4%2up+150.6%1.61No estimate
KERALAAYURVEDALTD Healthcare30up+21.5%up+10.7%4n/a2.84No estimate
ONYX Onyx Biotec LtdHealthcare30up+26.2%n/a3up+86.9%2.24No estimate
MAKERSL Makers Laboratories LtdHealthcare30up+18.0%down−0.1%10n/a14.95No estimate
SMRUTHIORGANICSLTD Healthcare29down−0.7%up+7.8%1down−62.3%0.68No estimate
KIMIABIOSCIENCESLTD Healthcare28up+16.4%up+25.8%2n/a0.34No estimate
QUESTLAB Quest Laboratories LtdHealthcare27n/aup+79.5%6n/a3.70No estimate
PANCHSHEELORGANICSLTD Healthcare27up+14.6%up+4.3%4up+2.7%2.88No estimate
Panchsheel Organics Ltd Healthcare27up+14.6%up+4.3%4up+2.7%2.88No estimate
GODAVARIDRUGSLTD Healthcare26down−34.0%down−19.0%1up+26.7%1.45No estimate
ROOPAINDUSTRIESLTD Healthcare26up+81.0%down−25.8%1down−3.3%0.74No estimate
WELCUREDRUGSPHARMACEUTICALSLTD Welcure Drugs & Pharmaceuticals LtdHealthcare25n/an/a2n/a0.01No estimate
VIVIMEDLAB Vivimed Labs LtdHealthcare25down−26.5%down−13.8%−5n/a−0.62No estimate
ALPA Alpa Laboratories LtdHealthcare25down−23.0%up+16.3%8up+32.8%3.65No estimate
SHELTERPHARMALTD Healthcare24up+24.6%n/a4up+14.2%3.06No estimate
EARKARTLTD Earkart LimitedHealthcare24n/an/a3n/a3.18No estimate
AMWILLHEALTHCARELTD Healthcare23n/an/a7n/a4.18No estimate
ROYALSENSELTD Healthcare22n/an/a2n/a4.86No estimate
VALIANTLAB Valiant Laboratories LtdHealthcare21down−65.0%up+10.5%−5down−600.0%−0.87No estimate
BROOKS Brooks Laboratories LtdHealthcare21down−14.5%up+16.0%−4n/a−1.51No estimate
TYCHEINDUSTRIESLTD Healthcare21up+28.1%up+32.3%4up+27.1%3.89No estimate
SUNLOC Sunil Healthcare LtdHealthcare20down−14.5%down−5.8%−1n/a−0.54No estimate
Omega Laboratories Ltd Healthcare19up+137.7%n/a2up+354.5%0.97No estimate
Cian Healthcare Ltd Healthcare19down−42.4%n/a−18n/a−7.30No estimate
VINEETLAB Vineet Laboratories LtdHealthcare19down−56.3%down−20.5%−2down−175.6%−0.95No estimate
ACCPL Accretion Pharmaceuticals LtdHealthcare19n/an/a2n/a3.01No estimate
MERCURYLABORATORIESLTD Healthcare18down−20.1%up+9.1%1down−66.9%4.17No estimate
SANJIVANIPARANTERALLTD Healthcare18n/aup+10.3%2n/a1.97No estimate
AMKAYPRODUCTSLTD Healthcare18up+24.1%n/a2up+40.8%2.11No estimate
SANDUPHARMACEUTICALSLTD Healthcare18up+6.6%up+3.8%1down−9.1%0.52No estimate
RAJNISHWELLNESSLTD Healthcare17down−5.9%up+6.9%0up+180.0%0.00No estimate
GML Galaxy Medicare LtdHealthcare17n/an/a2n/a1.44No estimate
MEDIORG Medicamen Organics LtdHealthcare17n/an/a2n/a1.29No estimate
PREVESTLTD Prevest Denpro LtdHealthcare16up+23.4%up+21.9%5up+29.4%4.03No estimate
BDHINDUSTRIESLTD Healthcare16down−16.1%down−0.2%2down−4.0%4.19No estimate
CURIS Curis Lifesciences LtdHealthcare16n/an/a2n/a4.00No estimate
TRIDENTLIFELINELTD Healthcare15n/aup+17.5%3n/a2.69No estimate
SUNREST Sunrest Lifescience LtdHealthcare15n/an/a1n/a1.35No estimate
CENTENIALSURGICALSUTURELTD Healthcare14up+8.9%up+3.9%0down−45.8%0.36No estimate
OXYGENTAPHLTD Oxygenta Pharmaceutical LtdHealthcare14up+7.1%up+11.0%−3n/a−0.80No estimate
GUJARATTERCELABORATORIESLTD Healthcare13up+10.6%up+11.9%1up+348.5%1.99No estimate
SPARC Sun Pharma Advanced Research Company LtdHealthcare13down−38.1%down−23.5%−108n/a−3.32No estimate
KREBSBIO Krebs Biochemicals & Industries LtdHealthcare13down−13.6%down−0.2%−6n/a−2.67No estimate
VIVOBIOT Vivo Bio Tech LtdHealthcare12up+30.0%up+18.9%5up+1,484.8%3.51No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare12down−95.9%down−63.6%0down−100.0%0.07No estimate

About Q2 FY25 earnings data

When are Q2 FY25 results announced?
Q2 FY25 covers the Jul–Sep 2024 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q2 FY25 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No analyst consensus was available for Q2 FY25, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q2 FY25?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.